Page last updated: 2024-08-17

quinoxalines and s 1033

quinoxalines has been researched along with s 1033 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dörken, B; Grille, P; Kaeda, J; le Coutre, P; Manley, PW; Marque, F; Oberender, C; Radimerski, T; Ringel, F; Schwarz, M1

Other Studies

1 other study(ies) available for quinoxalines and s 1033

ArticleYear
Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
    Acta haematologica, 2014, Volume: 132, Issue:1

    Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Janus Kinase 2; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Myeloproliferative Disorders; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Quinoxalines; STAT5 Transcription Factor; Tumor Suppressor Proteins

2014